For example, in a study by Asaoka et al. [19], the pCR rates after NAC were 52.9% in HER2-positive/HR-negative breast cancer, 34.2% in TNBC, and 14.7% in HR-positive/HER2-negative breast cancer. Here, ERBB2 is linked to breast cancer.